pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Zalviso
drug · small molecule
save

sufentanil citrate

Marketedupdated 5mo ago
by $TLPH TALPHERA, INC.🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval140 co-mentions · 35 sources
  • drugSUFENTA PRESERVATIVE FREE131 co-mentions · 36 sources
  • drugsufentanil71 co-mentions · 36 sources
  • tagDrug Shortage1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval, with an approval for pain.

targets

Mu-type opioid receptor

all catalysts(30)

approval · 30
May 4, 1984
approval
42y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Sep 10, 1984
approval
42y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 21, 1985
approval
41y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 21, 1985
approval
41y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 18, 1986
approval
41y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 18, 1986
approval
41y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 20, 1986
approval
40y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 6, 1986
approval
40y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 14, 1986
approval
40y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 14, 1986
approval
40y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Apr 29, 1987
approval
39y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Oct 5, 1990
approval
36y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 10, 1992
approval
34y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 19, 1993
approval
34y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
33y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
33y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
33y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Feb 22, 1995
approval
32y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 21, 1996
approval
30y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 12, 1997
approval
29y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 1, 1998
approval
28y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 26, 1998
approval
28y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 25, 1999
approval
27y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 27, 2001
approval
25y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 4, 2007
approval
19y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 20, 2014
approval
13y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 16, 2016
approval
10y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Oct 7, 2019
approval
7y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 15, 2023
approval
3y ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 22, 2025
approval
9mo ago
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
view all 30 catalysts →

Patent cliff

source: FDA Orange Book
first barrier falls
Jan 5, 2027
97 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (21)

  • Feb 2, 2038formulationUS 11672738
  • Jul 29, 2031formulationUS 89455924.8y
  • Oct 22, 2030method-of-use (U-1351)US 82025354.1y
  • Oct 22, 2030method-of-use (U-1351)US 88657434.1y
  • Mar 16, 2030formulationUS 108967513.5y
  • Mar 16, 2030formulationUS 116766913.5y
  • Mar 16, 2030formulationUS 120337333.5y
  • Mar 16, 2030formulationUS 85741893.5y
  • Jan 5, 2027formulationUS 1024522897d
  • Jan 5, 2027formulationUS 1034276297d
  • Jan 5, 2027formulationUS 1050718097d
  • Jan 5, 2027formulationUS 822697897d
  • Jan 5, 2027formulationUS 823190097d
  • Jan 5, 2027formulationUS 825232897d
  • Jan 5, 2027formulationUS 825232997d
  • Jan 5, 2027formulationUS 853571497d
  • Jan 5, 2027method-of-use (U-1351)US 877839397d
  • Jan 5, 2027method-of-use (U-1351)US 877839497d
  • Jan 5, 2027method-of-use (U-1351)US 886521197d
  • Jan 5, 2027method-of-use (U-1351)US 932071097d
  • Jan 5, 2027formulationUS 974412997d

News(0)

no news has mentioned this drug yet

brand
Zalviso
trade names
Dsuvia, Dzuveo, Sufenta, Sufenta preservative free, Sufental, Sufentanil citrate
generic
sufentanil citrate
MOA
Mu opioid receptor agonist
indication
Post-Operative Pain
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 21m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?